Gabapentin NDC 43547-480

NDC codes

FDA NDC Directory

Product NDC (as listed)43547-480Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43547-0480Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
43547-480-10	43547048010	100 CAPSULE in 1 BOTTLE (43547-480-10)Marketed from Apr 29, 2026
43547-480-11	43547048011	1000 CAPSULE in 1 BOTTLE (43547-480-11)Marketed from Apr 29, 2026
43547-480-50	43547048050	500 CAPSULE in 1 BOTTLE (43547-480-50)Marketed from Apr 29, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Solco Healthcare US, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219814
Marketing start: Apr 29, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 43547-480_2d83d237-09b6-4784-ab1e-eb1609ed2ca3SPL ID 2d83d237-09b6-4784-ab1e-eb1609ed2ca3SPL set ID 360d953b-4313-45ae-b933-296547d4577dRxCUI 310430, 310431, 310432UNII 6CW7F3G59XUPC 0343547481506, 0343547480509, 0343547479503

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443547048010 followed by a unit qualifier and the quantity

Package 43547-0480-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 28, 2026.

Indications (excerpt from the label)

Gabapentin capsules are indicated for: • Management of postherpetic neuralgia in adults • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin capsules are indicated for: • Postherpetic neuralgia in adults ( 1 ) • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219814

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219814
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-481
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-479